While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...
Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded. As of April 2, 2026, the State Street SPDR S&P Biotech ETF (NYSE:XBI) ...
Iovance Biotherapeutics argues that there is a meaningful opportunity here of more than 8,000 patients diagnosed annually in ...
4d
Adaptive Biotech Insider Sells $554K as Revenue Jumps 55%, but Here's What Investors Should Focus On
This immuno-driven diagnostics company, known for partnerships with Genentech and Microsoft, just reported a notable insider ...
The companies Earendil Labs, Teva Pharmaceuticals, and Solid Biosciences bagged the biggest biotech funding rounds overall in ...
ORLANDO, FL / ACCESS Newswire / April 10, 2026 / RedChip Companies, an industry leader in investor relations, media, ...
This year’s conference lineup includes Dr. Makoto Kuro-o, the physician-scientist widely recognized for discovering the Klotho gene. Being invited to present alongside that caliber of speaker puts ...
Focused on infectious disease therapies, this biotech firm reported a notable insider sale amid a year of strong share price gains.
Integrated consulting approach streamlines pathway from concept to commercialization NEW YORK, NY, UNITED STATES, April ...
One of the world’s largest biotech companies is closing its only office in the Bay Area. Pfizer is shutting down its office ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results